Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States

Rahul Aggarwal, Muthiah Vaduganathan, Nicholas Chiu, Deepak L. Bhatt

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations

Original language	English
Pages (from-to)	97-98
Number of pages	2
Journal	Progress in Cardiovascular Diseases
Volume	68
DOIs	https://doi.org/10.1016/j.pcad.2021.09.007
State	Published - 1 Sep 2021
Externally published	Yes

Access to Document

@article{e40fe43a650342368edd50b5a932c102,

title = "Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States",

author = "Rahul Aggarwal and Muthiah Vaduganathan and Nicholas Chiu and Bhatt, {Deepak L.}",

year = "2021",

month = sep,

day = "1",

doi = "10.1016/j.pcad.2021.09.007",

language = "English",

volume = "68",

pages = "97--98",

journal = "Progress in Cardiovascular Diseases",

issn = "0033-0620",

publisher = "W.B. Saunders",

}

TY - JOUR

T1 - Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States

AU - Aggarwal, Rahul

AU - Vaduganathan, Muthiah

AU - Chiu, Nicholas

AU - Bhatt, Deepak L.

PY - 2021/9/1

Y1 - 2021/9/1

UR - http://www.scopus.com/inward/record.url?scp=85117879901&partnerID=8YFLogxK

U2 - 10.1016/j.pcad.2021.09.007

DO - 10.1016/j.pcad.2021.09.007

M3 - Letter

C2 - 34560122

AN - SCOPUS:85117879901

SN - 0033-0620

VL - 68

SP - 97

EP - 98

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

ER -